INDP

Indaptus TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

20%

Probability

Target price

$2.50

+16.3% vs current

Most likely

Base case

45%

Probability

Target price

$1.00

-53.5% vs current

B-

Bear case

35%

Probability

Target price

$0.25

-88.4% vs current

AI sentiment snapshot

Latest data as of 2026-05-27

AI commentary

Cautious monitoring stance. The packet is filing-driven, not news-driven, and contains no recent trusted-news or social signal. Primary evidence points to a very tight cash runway, ongoing burn, and a program reset, while post-print price reaction and analyst revision data are unavailable in the packet. That keeps conviction low and the setup dependent on financing or a credible funded development path rather than operating momentum.

RankAlpha Sentiment Codex - 2026-05-27

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-15eventQ1 results showed lower loss but did not solve cash burnHigh impact

The May 15 press release/8-K framed Q1 2026 results as a lower net loss year over year, but operating cash use remained elevated, so the improvement in the P&L did not remove the funding overhang [#8-K-2026-05-15].

2026-06-30catalystRunway pressure and dilution risk stay immediateHigh impact

The May 15 10-Q/8-K package says cash and cash equivalents were about $1.5 million at March 31, 2026 and management expected funding only through Q2 2026, leaving fresh capital or strategic financing as the key near-term variable [#10-Q-2026-05-15][#8-K-2026-05-15].

2026-12-31catalystAny Decoy20 restart or partnership would be the main upside leverHigh impact

Management said it discontinued further enrollment in the Combination Study and is reevaluating Decoy20 and development priorities, so a durable re-rating likely requires a funded restart, partnership, or other concrete strategic path [#8-K-2026-05-15].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-27 • Updated nightlySource: Internal modelMethodology